{"text": ["U.S.", "drugmakers", "file", "lawsuit", "against", "rule", "requiring", "drug", "prices", "in", "TV", "ads"], "created_at": "2019-06-14 19:14:27"}
{"text": ["Pharma", "Stock", "Roundup:", "MRK", "Buys", "Small", "Cancer", "Biotech,", "RHHBY,", "MRK", "Drugs", "Get", "FDA", "Nod"], "created_at": "2019-06-14 12:42:12"}
{"text": ["Lilly", "Presents", "Positive", "Results", "for", "Taltz\u00ae", "(ixekizumab)", "vs.", "Humira\u00ae", "(adalimumab)", "in", "a", "Head-to-Head", "(SPIRIT-H2H)", "Superiority", "Study", "in", "Patients", "with", "Active", "Psoriatic", "Arthritis", "at", "the", "European", "Congress", "of", "Rheumatology"], "created_at": "2019-06-14 10:45:00"}
{"text": ["Drugmakers", "sue", "to", "stop", "rule", "requiring", "prices", "in", "TV", "ads"], "created_at": "2019-06-14 09:19:10"}
